Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)
NCT03772197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138
Last updated 2018-12-19
Summary
A recurrence index for distant recurrence (RI-DR), an 18-gene-based clinical-genomic model, has been developed for early-stage breast cancer (EBC). In this study, Investigators compared the prognostic performance of the RI-DR with the Oncotype DX (ODx) recurrence score (RS) for any recurrence risk type.
Conditions
- Breast Cancer
- Recurrence
Sponsors & Collaborators
-
Amwise Diagnostics Pte. Ltd.
lead INDUSTRY
Principal Investigators
-
Skye Cheng · AMWISE DIAGNOSTICS PTE. LDT.
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2018-10-18
- Completion
- 2018-11-01
Countries
- Taiwan
Study Locations
More Related Trials
-
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NCT01420185 ·Status: UNKNOWN
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer
NCT04972448 ·Status: NOT_YET_RECRUITING
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
NCT02347449 ·Status: COMPLETED ·Phase: NA
-
MRD in High-risk EBC
NCT06566729 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
NCT02766881 ·Status: COMPLETED
-
Molecular Signature for Breast Cancer
NCT05724407 ·Status: UNKNOWN
-
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
NCT01423890 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
NCT02078570 ·Status: UNKNOWN
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678 ·Status: COMPLETED
-
Exploring a Breast Cancer Early Screening Model Based on cfDNA
NCT06016790 ·Status: COMPLETED
-
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
NCT01140776 ·Status: TERMINATED
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
NCT06102018 ·Status: RECRUITING
-
A Single-arm, Prospective, Multi-center Cohort Study Based on Deep Learning-based cfDNA Fragment Omics to Verify the TuFEst Model for the Staging Diagnosis of Breast Cancer Lesions and Lymph Nodes
NCT07304934 ·Status: NOT_YET_RECRUITING
-
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
NCT00323908 ·Status: COMPLETED
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis
NCT04179318 ·Status: UNKNOWN
-
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
NCT06979921 ·Status: ACTIVE_NOT_RECRUITING
-
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
NCT02411760 ·Status: COMPLETED
-
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
NCT07052734 ·Status: COMPLETED